临床医生对头颈癌监测降级的看法与信念
这项定性研究于2021年1月至3月访谈了21名耳鼻咽喉科和放射肿瘤科医生,探讨其对头颈癌监测降级的看法。参与者愿意考虑调整监测方案,但担忧降级可能增加患者焦虑并将复发监测负担转嫁给患者,同时强调需维持医患双方的安心感、医患关系及对治疗相关毒性的充分监测。
要点
- 参与医生对监测指南的解读存在较大差异,但愿意考虑降级监测或引入基于症状的监测方案。
- 医生担忧降级监测可能增加患者焦虑,并将部分复发监测负担转移给患者。
- 患者与医生的安心感、维持医患关系及充分管理治疗相关毒性是降级监测的重要障碍。
核心结论
- 临床医生表示愿意考虑调整癌症监测方案,但强调需维持患者与医生的安心感、维持医患关系,并确保对治疗相关毒性及其他生存期问题的充分监测。
研究设计与样本
- 定性研究,于2021年1月至3月开展,采用解释性描述方法指导访谈分析,数据分析于2021年3月至4月进行。
- 采用目的抽样和滚雪球抽样策略招募耳鼻咽喉科医生和放射肿瘤科医生,共访谈21名医生(17名[81%]男性),包括13名耳鼻咽喉科医生和8名放射肿瘤科医生,执业年限中位数为8年(IQR,5-20年)。
- 12名参与者(57%)表示其接诊患者中头颈癌患者占比超过75%。
主要发现
- 参与者表示对监测指南的解读存在显著差异。
- 参与者对监测降级或纳入基于症状的监测方案持开放态度,但担忧降级监测可能增加患者焦虑并将部分复发监测负担转移给患者。
- 患者和医生的安心感、维持医患关系的重要性以及充分的生存期管理和治疗相关毒性管理需求,被报告为降级监测的重要障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Surveillance imaging and visits are costly and have not been shown to improve oncologic outcomes for patients with head and neck cancer (HNC). However, the benefit of surveillance visits may extend beyond recurrence detection. To better understand surveillance and potentially develop protocols to tailor current surveillance paradigms, it is important to elicit the perspectives of the clinicians who care for patients with HNC. OBJECTIVE: To characterize current surveillance practices and explore clinician attitudes and beliefs on deintensifying surveillance for patients with HNC. DESIGN, SETTING, AND PARTICIPANTS: This qualitative study was performed from January to March 2021. Guided by an interpretive description approach, interviews were analyzed to produce a thematic description. Data analysis was performed from March to April 2021. Otolaryngologists and radiation oncologists were recruited using purposive and snowball sampling strategies. MAIN OUTCOMES AND MEASURES: The main outcomes were current practice, attitudes, and beliefs about deintensifying surveillance and survivorship as well as patients' values and perspectives collected from interviews of participating physicians. RESULTS: Twenty-one physicians (17 [81%] men) were interviewed, including 13 otolaryngologists and 8 radiation oncologists with a median of 8 years (IQR, 5-20 years) in practice. Twelve participants (57%) stated their practice comprised more than 75% of patients with HNC. Participants expressed that there was substantial variation in the interpretation of the surveillance guidelines. Participants were open to the potential for deintensification of surveillance or incorporating symptom-based surveillance protocols but had concerns that deintensification may increase patient anxiety and shift some of the burden of recurrence monitoring to patients. Patient and physician peace of mind, the importance of maintaining the patient-physician relationship, and the need for adequate survivorship and management of treatment-associated toxic effects were reported to be important barriers to deintensifying surveillance. CONCLUSIONS AND RELEVANCE: In this qualitative study, clinicians revealed a willingness to consider altering cancer surveillance but expressed a need to maintain patient and clinician peace of mind, maintain the patient-clinician relationship, and ensure adequate monitoring of treatment-associated toxic effects and other survivorship concerns. These findings may be useful in future research on the management of posttreatment surveillance.
引用
- Chen MM, Mott NM, Miller J, et al. Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34734995. doi:10.1001/jamaoto.2021.2824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。